APA (7th ed.) Citation

T, G., T, K., L, H., TE, W., AS, C., S, S., . . . MM, H. (2025). Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier. Molecular pharmaceutics, 22(12), 7600. https://doi.org/10.1021/acs.molpharmaceut.5c01180

Chicago Style (17th ed.) Citation

T, Gustavsson, et al. "Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier." Molecular Pharmaceutics 22, no. 12 (2025): 7600. https://doi.org/10.1021/acs.molpharmaceut.5c01180.

MLA (9th ed.) Citation

T, Gustavsson, et al. "Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier." Molecular Pharmaceutics, vol. 22, no. 12, 2025, p. 7600, https://doi.org/10.1021/acs.molpharmaceut.5c01180.